Global Endoscope Reprocessing Market Key Player, Trends, Analysis And Forecast 2018-2023

By -

The Endoscope Reprocessing Market market is projected to reach USD 2.15 billion by 2022 at a CAGR of 8.6%.

(EMAILWIRE.COM, December 20, 2018 ) The Market Research on Endoscope Reprocessing, By Considering useful aspects like; Product, End Users- Global Future Forecast till 2022, published by MarketsandMarkets™, the report studies the global Endoscope Reprocessing market over the forecast period to 2022.

Automated Endoscope Reprocessors (AERs) to account for the largest share of the endoscope reprocessing market in 2017

On the basis of products, the market is segmented into high-level disinfectants and test strips; detergents and wipes; endoscope tracking systems; endoscope drying, storage, and transport systems; automated endoscope reprocessors (AERs); and other products (brushes and flushing aids, leak testers, hookups, and sponges). The high-level disinfectants and test strips segment is expected to account for the largest share of the global endoscope reprocessing market in 2017. The large share of this segment is attributed to the increasing outbreaks linked to inadequate cleaning or disinfecting during HLD, the effectiveness of high-level disinfectants for quality assurance in decontaminating endoscopes, and rising adherence to endoscope reprocessing guidelines by healthcare centers.

Request a Sample Copy of “Endoscope Reprocessing Market” Consist 65 tables and 27 figures spread over 155 pages and in-depth TOC: https://www.marketsandmarkets.com/requestsample.asp?id=219094994

Hospitals segment expected to account for the largest share of the market in 2017

On the basis of end user, the endoscope reprocessing market has been segmented into hospitals, ambulatory surgery centers, and other end users (diagnostic centers, mobile endoscopy facilities, and office endoscopy centers). In 2017, the hospitals segment is expected to account for the largest share of the global endoscope reprocessing market. The ambulatory surgery centers (ASCs) segment, on the other hand, is expected to be the fastest-growing segment during the forecast period. The high growth in this segment can be attributed to the increase in the number of endoscopic procedures performed in ASCs, and rising preference of ASCs over hospitals.

North America accounted for the largest share of the endoscope reprocessing market in 2017, followed by Europe. In the US, the endoscope reprocessing market is driven by the favorable reimbursement scenario, rising incidence of cancer, increasing investments by hospitals to purchase new endoscopic equipment, and increasing incidence of endoscope-related infections. In Canada, the growth of the endoscope reprocessing market is driven by the availability of physician bonuses, and implementation of a new funding model for Canadian hospitals.

Request Free Research Sample: https://www.marketsandmarkets.com/requestsampleNew.asp?id=219094994

Media Contact

Related Tags

Read other news from MarketsandMarkets™

Timing Devices Market Size, Share, Revenue Trends & Forecast to 2030

MarketsandMarkets™ - Sep 18, 2023
Timing Devices Market by Type (Oscillators, Atomic Clocks, Clock Generators, Clock Buffers, Jitter Attenuators), Material (Crystal, Silicon, Ceramic), Vertical (Consumer Electronics, Automotive) and Region - Global Forecast to 2030 ...Read more

Artificial Intelligence Market Segmented by Product, Top Manufacturers, Geography Trends & Growth Opportunity to 2030

MarketsandMarkets™ - Sep 18, 2023
Artificial Intelligence technology such as machine learning, natural language processing, computer vision, and others are revolutionizing various sectors, including healthcare, finance, manufacturing, and retail. ...Read more

Digital PCR (dPCR) and Real-time PCR (qPCR) Market worth $12.4 billion by 2028, at a CAGR of 7.8%.

MarketsandMarkets™ - Sep 18, 2023
"Digital PCR (dPCR) and Real-time PCR (qPCR) Market by Product (Instruments, Reagents & Consumables, Software & Services), Application (Clinical, Research, Forensic), End User (Hospital, Diagnostic Labs, Pharma, Biotech, CROs) - Global Forecast to 2028". ...Read more